title: Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies.
abstract: This evidence-based review will discuss the current standard of adjuvant chemotherapy for resected high-risk colon cancer and address existing controversies including strategies for risk-stratification, the status of targeted therapy, treatment of the elderly and the optimal duration of therapy.
authors.affiliation: Department of Medicine, Division of Medical Oncology, University of British Columbia, Vancouver, Canada.
authors.forename: Sharlene
authors.initials: S
authors.lastname: Gill
keywords: 5-FU; Adjuvant therapy; colon cancer; oxaliplatin; stage II